Cargando…

E-cadherin re-expression shows in vivo evidence for mesenchymal to epithelial transition in clonal metastatic breast tumor cells

Substantial experimental evidence has shown that dedifferentiation from an epithelial state to a mesenchymal-like state (EMT) drives tumor cell metastasis. This transition facilitates tumor cells to acquire motility and invasive features. Intriguingly, tumor cells at the metastatic site are primaril...

Descripción completa

Detalles Bibliográficos
Autores principales:	Palen, Katie, Weber, James, Dwinell, Michael B., Johnson, Bryon D., Ramchandran, Ramani, Gershan, Jill A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5190029/ https://www.ncbi.nlm.nih.gov/pubmed/27270319 http://dx.doi.org/10.18632/oncotarget.9715

Ejemplares similares

Adoptive cellular therapy using bone marrow-derived T cells for the treatment of childhood leukemia
por: Gershan, Jill, et al.
Publicado: (2015)

Bone Marrow-derived CD8(+) T Cells From Pediatric Leukemia Patients Express PD1 and Expand Ex Vivo Following Induction Chemotherapy
por: Palen, Katie, et al.
Publicado: (2019)

STING agonist inflames the pancreatic cancer immune microenvironment and reduces tumor burden in mouse models
por: Jing, Weiqing, et al.
Publicado: (2019)

Astrocytes Directly Influence Tumor Cell Invasion and Metastasis In Vivo
por: Wang, Ling, et al.
Publicado: (2013)

Correction: Astrocytes Directly Influence Tumor Cell Invasion and Metastasis In Vivo
por: Wang, Ling, et al.
Publicado: (2015)

Breast carcinoma cells re-express E-cadherin during mesenchymal to epithelial reverting transition
por: Chao, Yvonne L, et al.
Publicado: (2010)

Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models
por: Tsai, Susan, et al.
Publicado: (2018)

E-cadherin on epithelial–mesenchymal transition in thyroid cancer
por: Zhu, Xiaoyu, et al.
Publicado: (2021)

Adoptive cell therapy using PD-1(+) myeloma-reactive T cells eliminates established myeloma in mice
por: Jing, Weiqing, et al.
Publicado: (2017)

The E-Cadherin and N-Cadherin Switch in Epithelial-to-Mesenchymal Transition: Signaling, Therapeutic Implications, and Challenges
por: Loh, Chin-Yap, et al.
Publicado: (2019)

Cyclophosphamide in combination with tumor lysate and TLR9 ligand regresses murine neuroblastoma
por: Gershan, Jill, et al.
Publicado: (2013)

Role of N-Cadherin in Epithelial-to-Mesenchymal Transition and Chemosensitivity of Colon Carcinoma Cells
por: Skarkova, Veronika, et al.
Publicado: (2022)

N-Cadherin Extracellular Repeat 4 Mediates Epithelial to Mesenchymal Transition and Increased Motility
por: Kim, Jae-Beom, et al.
Publicado: (2000)

Loss of E-cadherin and epithelial to mesenchymal transition is not required for cell motility in tissues or for metastasis
por: Liu, Xiang, et al.
Publicado: (2014)

Roles of E-cadherin and Noncoding RNAs in the Epithelial–mesenchymal Transition and Progression in Gastric Cancer
por: Bure, Irina V., et al.
Publicado: (2019)

Significance of E-cadherin and Vimentin as epithelial-mesenchymal transition markers in colorectal carcinoma prognosis
por: Niknami, Zohreh, et al.
Publicado: (2020)

BTBD7 Downregulates E-Cadherin and Promotes Epithelial-Mesenchymal Transition in Lung Cancer
por: Shu, Jie, et al.
Publicado: (2019)

A re-appraisal of mesenchymal-epithelial transition (MET) in endometrial epithelial remodeling
por: Spooner-Harris, Madelyn, et al.
Publicado: (2022)

Re-evaluating the role of epithelial-mesenchymal-transition in cancer progression
por: Sulaiman, Andrew, et al.
Publicado: (2018)

Role of epithelial-mesenchymal transition markers E-cadherin, N-cadherin, β-catenin and ZEB2 in laryngeal squamous cell carcinoma
por: Zhu, Guang-Jie, et al.
Publicado: (2018)

VEGF Mediates Tumor Growth and Metastasis by Affecting the Expression of E-Cadherin and N-Cadherin Promoting Epithelial to Mesenchymal Transition in Gastric Cancer
por: Zhang, Yue, et al.
Publicado: (2023)

A Positive Role of Cadherin in Wnt/β-Catenin Signalling during Epithelial-Mesenchymal Transition
por: Howard, Sara, et al.
Publicado: (2011)

Cadherin-6B is proteolytically processed during epithelial-to-mesenchymal transitions of the cranial neural crest
por: Schiffmacher, Andrew T., et al.
Publicado: (2014)

MiR-429 reverses epithelial-mesenchymal transition by restoring E-cadherin expression in bladder cancer
por: Wu, Chia-Lun, et al.
Publicado: (2016)

SIRT1 induces epithelial-mesenchymal transition by promoting autophagic degradation of E-cadherin in melanoma cells
por: Sun, Ting, et al.
Publicado: (2018)

Oncogenic effect of PHLDB2 is associated with epithelial–mesenchymal transition and E-cadherin regulation in colorectal cancer
por: Chen, Geng, et al.
Publicado: (2019)

Cadherin 13 Inhibits Pancreatic Cancer Progression and Epithelial-mesenchymal Transition by Wnt/β-Catenin Signaling
por: Xu, Dengfei, et al.
Publicado: (2020)

Epithelial–mesenchymal transition in cancer stem cells: Therapeutic implications
por: Varun, BR, et al.
Publicado: (2023)

Distinct Mesenchymal Alterations in N-Cadherin and E-Cadherin Positive Primary Renal Epithelial Cells
por: Keller, Christof, et al.
Publicado: (2012)

Immune modulating effects of cyclophosphamide and treatment with tumor lysate/CpG synergize to eliminate murine neuroblastoma
por: Gershan, Jill A., et al.
Publicado: (2015)

EPB41L5 functions to post-transcriptionally regulate cadherin and integrin during epithelial–mesenchymal transition
por: Hirano, Mariko, et al.
Publicado: (2008)

Loss of E-cadherin expression is not a prerequisite for c-erbB2-induced epithelial-mesenchymal transition
por: NILSSON, GISELA M.A., et al.
Publicado: (2014)

Loss of E-cadherin and Acquisition of Vimentin in Epithelial-Mesenchymal Transition are Noble Indicators of Uterine Cervix Cancer Progression
por: Myong, Na-Hye
Publicado: (2012)

Small molecule/ML327 mediated transcriptional de-repression of E-cadherin and inhibition of epithelial-to-mesenchymal transition
por: An, Hanbing, et al.
Publicado: (2015)

Cadherin-6B proteolysis promotes the neural crest cell epithelial-to-mesenchymal transition through transcriptional regulation
por: Schiffmacher, Andrew T., et al.
Publicado: (2016)

PHF8 upregulation contributes to autophagic degradation of E-cadherin, epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma
por: Zhou, Wuhua, et al.
Publicado: (2018)

Actin Cytoskeleton Regulation of Epithelial Mesenchymal Transition in Metastatic Cancer Cells
por: Shankar, Jay, et al.
Publicado: (2015)

Role of the ABL tyrosine kinases in the epithelial–mesenchymal transition and the metastatic cascade
por: Luttman, Jillian Hattaway, et al.
Publicado: (2021)

SOX11 and Epithelial-Mesenchymal Transition in Metastatic Serous Ovarian Cancer
por: Psilopatis, Iason, et al.
Publicado: (2023)

Chlamydia trachomatis Infection Is Associated with E-Cadherin Promoter Methylation, Downregulation of E-Cadherin Expression, and Increased Expression of Fibronectin and α-SMA—Implications for Epithelial-Mesenchymal Transition
por: Rajić, Jovana, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_rvks465i5q3bib2sshvqpr6psm